Lactating 0 9 0 9 O
females 10 17 10 17 B-gender
may 18 21 18 21 O
not 22 25 22 25 O
participate 26 37 26 37 O
unless 38 44 38 44 O
they 45 49 45 49 O
have 50 54 50 54 O
agreed 55 61 55 61 O
not 62 65 62 65 O
to 66 68 66 68 O
breastfeed 69 79 69 79 O
a 80 81 80 81 O
child 82 87 82 87 O
while 88 93 88 93 O
on 94 96 94 96 O
this 97 101 97 101 O
study 102 107 102 107 O

Males 0 5 108 113 B-gender
and 6 9 114 117 O
females 10 17 118 125 B-gender
of 18 20 126 128 O
reproductive 21 33 129 141 O
potential 34 43 142 151 O
may 44 47 152 155 O
not 48 51 156 159 O
participate 52 63 160 171 O
unless 64 70 172 178 O
they 71 75 179 183 O
have 76 80 184 188 O
agreed 81 87 189 195 B-contraception_consent
to 88 90 196 198 I-contraception_consent
use 91 94 199 202 I-contraception_consent
an 95 97 203 205 I-contraception_consent
effective 98 107 206 215 I-contraception_consent
contraceptive 108 121 216 229 I-contraception_consent
method 122 128 230 236 I-contraception_consent

No 0 2 237 239 O
prior 3 8 240 245 B-treatment
treatment 9 18 246 255 I-treatment
other 19 24 256 261 O
than 25 29 262 266 O
surgical 30 38 267 275 B-treatment
intervention 39 51 276 288 I-treatment
and 52 55 289 292 O
corticosteroids 56 71 293 308 B-treatment
; 71 72 308 309 O
patients 73 81 310 318 O
are 82 85 319 322 O
allowed 86 93 323 330 O
to 94 96 331 333 O
have 97 101 334 338 O
had 102 105 339 342 O
more 106 110 343 347 O
than 111 115 348 352 O
one 116 119 353 356 B-lower_bound
attempt 120 127 357 364 O
at 128 130 365 367 O
resection 131 140 368 377 B-treatment
prior 141 146 378 383 O
to 147 149 384 386 O
enrollment 150 160 387 397 O

Patients 0 8 398 406 O
must 9 13 407 411 O
be 14 16 412 414 O
newly 17 22 415 420 O
diagnosed 23 32 421 430 O
with 33 37 431 435 O
histologically 38 52 436 450 O
confirmed 53 62 451 460 O
intracranial 63 75 461 473 B-cancer
ependymoma 76 86 474 484 I-cancer
; 86 87 484 485 O
patients 88 96 486 494 O
with 97 101 495 499 O
classic 102 109 500 507 O
ependymoma 110 120 508 518 B-cancer
( 121 122 519 520 I-cancer
WHO 122 125 520 523 I-cancer
II 126 128 524 526 I-cancer
) 128 129 526 527 I-cancer
or 130 132 528 530 O
anaplastic 133 143 531 541 B-cancer
ependymoma 144 154 542 552 I-cancer
( 155 156 553 554 I-cancer
WHO 156 159 554 557 I-cancer
III 160 163 558 561 I-cancer
) 163 164 561 562 I-cancer
are 165 168 563 566 O
eligible 169 177 567 575 O
, 177 178 575 576 O
as 179 181 577 579 O
are 182 185 580 583 O
various 186 193 584 591 O
subtypes 194 202 592 600 O
described 203 212 601 610 O
as 213 215 611 613 O
clear 216 221 614 619 O
cell 222 226 620 624 O
, 226 227 624 625 O
papillary 228 237 626 635 O
, 237 238 635 636 O
cellular 239 247 637 645 O
or 248 250 646 648 O
a 251 252 649 650 O
combination 253 264 651 662 O
of 265 267 663 665 O
the 268 271 666 669 O
above 272 277 670 675 O

Patients 0 8 676 684 O
with 9 13 685 689 O
a 14 15 690 691 O
diagnosis 16 25 692 701 O
of 26 28 702 704 O
spinal 29 35 705 711 B-cancer
cord 36 40 712 716 I-cancer
ependymoma 41 51 717 727 I-cancer
, 51 52 727 728 O
myxopapillary 53 66 729 742 B-cancer
ependymoma 67 77 743 753 I-cancer
, 77 78 753 754 O
subependymoma 79 92 755 768 B-cancer
, 92 93 768 769 O
ependymoblastoma 94 110 770 786 B-cancer
, 110 111 786 787 O
or 112 114 788 790 O
mixed 115 120 791 796 B-cancer
glioma 121 127 797 803 I-cancer

Post 0 4 804 808 O
- 4 5 808 809 O
menarchal 5 14 809 818 O
females 15 22 819 826 B-gender
may 23 26 827 830 O
not 27 30 831 834 O
participate 31 42 835 846 O
unless 43 49 847 853 O
a 50 51 854 855 O
pregnancy 52 61 856 865 B-pregnancy
test 62 66 866 870 O
with 67 71 871 875 O
a 72 73 876 877 O
negative 74 82 878 886 O
result 83 89 887 893 O
has 90 93 894 897 O
been 94 98 898 902 O
obtained 99 107 903 911 O

Pregnant 0 8 912 920 B-pregnancy
female 9 15 921 927 B-gender
patients 16 24 928 936 I-gender

There 0 5 937 942 O
is 6 8 943 945 O
no 9 11 946 948 O
minimum 12 19 949 956 O
performance 20 31 957 968 O
level 32 37 969 974 O
; 37 38 974 975 O
children 39 47 976 984 O
with 48 52 985 989 O
ependymoma 53 63 990 1000 B-cancer
may 64 67 1001 1004 O
suffer 68 74 1005 1011 O
neurologic 75 85 1012 1022 B-chronic_disease
sequelae 86 94 1023 1031 I-chronic_disease
as 95 97 1032 1034 O
a 98 99 1035 1036 O
result 100 106 1037 1043 O
of 107 109 1044 1046 O
their 110 115 1047 1052 O
tumor 116 121 1053 1058 B-cancer
or 122 124 1059 1061 O
surgical 125 133 1062 1070 O
measures 134 142 1071 1079 O
taken 143 148 1080 1085 O
to 149 151 1086 1088 O
establish 152 161 1089 1098 O
a 162 163 1099 1100 O
diagnosis 164 173 1101 1110 O
and 174 177 1111 1114 O
resect 178 184 1115 1121 O
the 185 188 1122 1125 O
tumor 189 194 1126 1131 O
; 194 195 1131 1132 O
in 196 198 1133 1135 O
the 199 202 1136 1139 O
majority 203 211 1140 1148 O
of 212 214 1149 1151 O
cases 215 220 1152 1157 O
, 220 221 1157 1158 O
there 222 227 1159 1164 O
is 228 230 1165 1167 O
neurologic 231 241 1168 1178 O
recovery 242 250 1179 1187 O
; 250 251 1187 1188 O
neurologic 252 262 1189 1199 O
recovery 263 271 1200 1208 O
is 272 274 1209 1211 O
not 275 278 1212 1215 O
likely 279 285 1216 1222 O
to 286 288 1223 1225 O
be 289 291 1226 1228 O
impeded 292 299 1229 1236 O
by 300 302 1237 1239 O
protocol 303 311 1240 1248 O
therapy 312 319 1249 1256 B-treatment

